Funded Startups in Woburn
Woburn entries span 2020-08-13 (Root AI) through 2025-11-18 (Nanoramic Laboratories), and the disclosed funding sizes show a steep hierarchy: Nanoramic Lab…
Woburn entries span 2020-08-13 (Root AI) through 2025-11-18 (Nanoramic Laboratories), and the disclosed funding sizes show a steep hierarchy: Nanoramic Laboratories’ $54M (2025-11-18) sits well above most other disclosed rounds, where several fall at $28M and below (e.g., Ossio $28M on 2024-12-02; Barricaid $56M is the only disclosed figure clearly above the rest of the 2023–2025 cluster range, but still far from the largest disclosed outlier set later in the list). A few entries are extreme outliers in the other direction: 100XBIO’s $60K (2025-04-04) and Imago Rehab’s $250K (2024-07-08) are orders of magnitude below the top disclosed rounds.
The date distribution also clusters at the high end: 15 of the 35 rows are dated 2024-11-13 through 2025-09-21, indicating heavier recent activity (e.g., Replimune Group $140M on 2024-11-25; Turing $14M on 2025-02-26; Hopewell Therapeutics $3M on 2025-09-21). Sector-wise, biotechnology is the most repeated category (11 of 35 entries), and “Series Unknown” appears frequently (20 of 35), with additional “undisclosed” disclosed amounts in 7 of 35 rows.
Most recent rounds
35 shownRelated listings
Frequently asked
What’s the largest disclosed round in this Woburn list, and how far above the rest are the remaining disclosed amounts?
The largest disclosed amount is Factorial Energy’s $200M (2022-01-20). The next-largest disclosed figures are in the $140M range (Replimune Group $140M on 2024-11-25), with most other disclosed rounds materially lower (e.g., Nanoramic Laboratories $54M on 2025-11-18; Turing $14M on 2025-02-26).
How concentrated are rounds near the most recent window (e.g., after 2024-11-13)?
15 of the 35 entries fall between 2024-11-13 and 2025-09-21, including large checks such as Replimune Group $140M (2024-11-25) and Ossio $28M (2024-12-02), plus smaller disclosed rounds like Hopewell Therapeutics $3M (2025-09-21). This makes the late-2024 to mid/late-2025 period the densest cluster in the dataset.
Which sectors are over-represented, and what does that suggest about focus?
Biotechnology is the dominant sector with 11 of 35 entries (e.g., Replimune Group $140M on 2024-11-25; AlpalifeBio $10M on 2025-09-09; Fieldstone Bio $5M on 2025-05-15). Energy is much less frequent at 4 of 35 (Nanoramic Laboratories $54M on 2025-11-18; Alsym Energy $78M on 2024-04-03; Feon $6M on 2024-06-27; Factorial Energy $200M on 2022-01-20).
Are there outliers in disclosed size that a diligence workflow should flag?
Yes. At the high end, Factorial Energy’s $200M (2022-01-20) and Replimune Group’s $140M (2024-11-25) stand far above most disclosed amounts; at the low end, 100XBIO shows just $60K (2025-04-04) and Imago Rehab shows $250K (2024-07-08).
How much of the list is “Series Unknown,” and does that limit comparability across rounds?
“Series Unknown” is used for 20 of 35 rows (e.g., Nanoramic Laboratories 2025-11-18 $54M; Turing 2025-02-26 $14M; Ossio 2024-12-02 $28M). That means round-stage comparability is constrained even when amounts are disclosed, since many entries do not specify Series A/B/C/D in the listing (contrasting with identified stages like Alsym Energy’s Series C $78M on 2024-04-03 and Factorial Energy’s Series D $200M on 2022-01-20).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.